NCT07006493View on ClinicalTrials.gov

REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy

NANot yet recruitingINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

December 30, 2027

Conditions

Hypertrophic Cardiomyopathy, Obstructive

Interventions

DEVICE

Transcatheter Intramyocardial Septal Radiofrequency Ablation System

The device system includes a single-use RF ablation catheter, sheath, RF generator, and irrigation pump. Ablation is guided by intracardiac echocardiography (ICE).

All Listed Sponsors

lead

SuZhou Sinus Medical Technologies Co.,Ltd

INDUSTRY